Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Express Scripts
Covington
AstraZeneca
Fuji
Baxter
Cerilliant
Daiichi Sankyo
Medtronic

Generated: June 21, 2018

DrugPatentWatch Database Preview

TRIPLE SULFAS Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Triple Sulfas, and when can generic versions of Triple Sulfas launch?

Triple Sulfas is a drug marketed by Lederle and is included in one NDA.

The generic ingredient in TRIPLE SULFAS is trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine). Additional details are available on the trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) profile page.
Summary for TRIPLE SULFAS
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 84
DailyMed Link:TRIPLE SULFAS at DailyMed
Drug patent expirations by year for TRIPLE SULFAS

US Patents and Regulatory Information for TRIPLE SULFAS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle TRIPLE SULFAS trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) SUSPENSION;ORAL 006920-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lederle TRIPLE SULFAS trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) TABLET;ORAL 006920-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office
Cipla
Boehringer Ingelheim
Fish and Richardson
Covington
Chubb
Fuji
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.